Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Journal
Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
11
11
2020
revised:
05
04
2021
accepted:
11
06
2021
pubmed:
30
6
2021
medline:
17
3
2022
entrez:
29
6
2021
Statut:
ppublish
Résumé
AURORA aims to study the processes of relapse in metastatic breast cancer (MBC) by performing multi-omics profiling on paired primary tumors and early-course metastases. Among 381 patients (primary tumor and metastasis pairs: 252 targeted gene sequencing, 152 RNA sequencing, 67 single nucleotide polymorphism arrays), we found a driver role for
Identifiants
pubmed: 34183353
pii: 2159-8290.CD-20-1647
doi: 10.1158/2159-8290.CD-20-1647
pmc: PMC9414283
doi:
Substances chimiques
Biomarkers, Tumor
0
Cell Cycle Proteins
0
MDM4 protein, human
0
Proto-Oncogene Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2796-2811Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : VA
ID : PEC 16-001
Pays : United States
Informations de copyright
©2021 The Authors; Published by the American Association for Cancer Research.
Références
Nature. 2012 May 16;486(7403):400-4
pubmed: 22722201
Eur J Cancer. 2019 Oct;120:54-64
pubmed: 31491604
Nature. 2019 May;569(7757):560-564
pubmed: 31118521
Genomics. 2000 Oct 15;69(2):271-4
pubmed: 11031110
Cancer Res. 2017 May 1;77(9):2213-2221
pubmed: 28249905
Ann Oncol. 2019 Mar 1;30(3):365-373
pubmed: 30715161
Oncologist. 2019 Jul;24(7):893-900
pubmed: 30679318
JAMA Oncol. 2017 Feb 01;3(2):227-234
pubmed: 27684533
Genome Biol. 2017 Nov 15;18(1):220
pubmed: 29141660
NPJ Breast Cancer. 2017 Jun 29;3:23
pubmed: 28685159
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
Cancer Cell. 2018 Sep 10;34(3):427-438.e6
pubmed: 30205045
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Ann Oncol. 2018 Nov 1;29(11):2232-2239
pubmed: 30203045
JNCI Cancer Spectr. 2018 Nov;2(4):pky062
pubmed: 30627694
Cancer Treat Rev. 2016 Nov;50:205-207
pubmed: 27744144
Breast Cancer Res. 2009;11(5):R77
pubmed: 19874578
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Nat Commun. 2019 Mar 26;10(1):1373
pubmed: 30914635
Cancer Discov. 2020 Jan;10(1):72-85
pubmed: 31594766
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Nat Genet. 2020 Jul;52(7):701-708
pubmed: 32424352
Breast Cancer Res. 2020 Aug 18;22(1):91
pubmed: 32811538
Ann Oncol. 2020 Nov;31(11):1491-1505
pubmed: 32853681
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Ann Oncol. 2019 Mar 1;30(3):397-404
pubmed: 30475950
N Engl J Med. 2014 Aug 7;371(6):583-4
pubmed: 25099597
Br J Cancer. 2014 Nov 11;111(10):1881-7
pubmed: 25225904
Clin Cancer Res. 2017 Aug 1;23(15):4242-4250
pubmed: 28351930
Nat Genet. 2019 Oct;51(10):1450-1458
pubmed: 31570896
Ann Oncol. 2020 Dec;31(12):1623-1649
pubmed: 32979513
Cancer Res. 2021 Jan 1;81(1):77-90
pubmed: 32967925
J Clin Oncol. 2020 Dec 20;38(36):4274-4282
pubmed: 33119476
J Clin Oncol. 2021 May 1;39(13):1458-1467
pubmed: 33769862
Nat Commun. 2020 May 1;11(1):2135
pubmed: 32358509
Oncologist. 2015 May;20(5):474-82
pubmed: 25908555
Nat Med. 2021 Jan;27(1):152-164
pubmed: 33398162
Cancer Cell. 2017 Aug 14;32(2):169-184.e7
pubmed: 28810143
Methods Mol Biol. 2018;1711:243-259
pubmed: 29344893
Mol Cancer Ther. 2004 Nov;3(11):1427-38
pubmed: 15542782
Oncotarget. 2015 Feb 28;6(6):4345-56
pubmed: 25726523
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
J Clin Invest. 2018 Apr 2;128(4):1371-1383
pubmed: 29480819
Nat Genet. 2019 Dec;51(12):1732-1740
pubmed: 31740835
NPJ Precis Oncol. 2020 Mar 16;4:6
pubmed: 32195359
Nat Genet. 2020 Feb;52(2):198-207
pubmed: 31932695
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346